Evaluation of pulsed electromagnetic field therapy for the treatment of chronic postoperative pain following lumbar surgery: a pilot, double-blind, randomized, sham-controlled clinical trial. 2018

Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
Alabama Orthopedic Center, Birmingham, AL, USA.

BACKGROUND The incidence of chronic postoperative pain following lumbar spinal surgery has increased with the overall increase in the prevalence of lumbar surgery. This study was conducted to evaluate the analgesic effectiveness of pulsed electromagnetic field (PEMF) therapy in subjects with persistent pain following lumbar surgery. METHODS A randomized, double-blind, sham-controlled, multicenter study in 36 subjects with persistent low-back and/or radiating leg pain after lumbar surgery was conducted. Eligible subjects were randomized (1:1:1) to receive one of two doses of therapy (42-μs or 38-μs pulse width) or treatment with a sham device. Subjects self-treated twice daily for 60 days. The primary end point was change in pain intensity (∆PI) using the Numerical Pain Rating Scale between average baseline (Days -5 to -1) and end of treatment (Days 56-60) for lumbar and radiating leg pain. Secondary outcome measures included the Oswestry Disability Index, Beck Depression Inventory-II, Patient Global Impression of Change, and consumption of analgesics. RESULTS Low-back pain scores for the 42-μs group decreased by 40.2% (p = 0.028), compared to 18.6% for the 38-μs pulse width group (p = 0.037) and 25.6% for the sham group (p = 0.013 per protocol population). Average leg pain scores decreased by 45.0% (42 μs, p = 0.009), 17.0% (38 μs, p = 0.293), and 24.5% (sham, p = 0.065). The proportion of subjects responding to therapy, time to 30% reduction in pain scores, and Patient Global Impression of Change were improved with the PEMF 42-μs device over the sham control, although results were associated with p-values >0.05. CONCLUSIONS PEMF therapy (42-μs pulse width) was associated with trends for a reduction in pain, compared to sham treatment. Secondary endpoints were consistent with an overall beneficial effect of the PEMF 42-μs pulse width device.

UI MeSH Term Description Entries

Related Publications

Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
October 2009, The Clinical journal of pain,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
January 2023, Bioelectromagnetics,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
January 2019, Journal of the American Animal Hospital Association,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
July 2012, Scandinavian journal of pain,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
November 2002, Wiener klinische Wochenschrift,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
August 2002, Wiener klinische Wochenschrift,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
February 2023, Journal of clinical medicine,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
February 2006, Rheumatology international,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
June 2019, Pain and therapy,
Robert Gordon Sorrell, and Jamie Muhlenfeld, and John Moffett, and Gary Stevens, and Steven Kesten
January 2006, The Journal of international medical research,
Copied contents to your clipboard!